Clin2
NCT07873632Likely a fitNot yet recruiting

Guaifenesin for mucus in chronic bronchitis

BronchitisBronchitis, Chronic

Part of Infections, Lungs & breathing clinical trials.

This study tests whether the over-the-counter medicine guaifenesin (also known as Mucinex) can make mucus easier to cough up in people with chronic bronchitis. It aims to see if this treatment helps clear mucus and improve breathing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
40 years to 75 years
Study type
Interventional

Who can take part

  • You are between 40 and 75 years old.
  • You have chronic bronchitis with a daily cough that produces mucus, lasting at least 3 months for 2 years in a row.
  • You have not had a recent flare-up of your breathing problems in the last month.
  • You have not used guaifenesin products (like Mucinex) in the past month.
  • You are not currently using certain other mucus-thinning medications or steroid pills.
  • You have a history of smoking for at least 10 years, but you have not smoked in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06242795Recruiting· Phase 4
Hypertonic saline for non-cystic fibrosis bronchiectasis

This trial tests whether inhaling a saltwater solution (hypertonic saline) twice a day for 12 weeks can help people with bronchiectasis who have a chronic cough and have had flare-ups in the past. It aims to see if this treatment reduces mucus and improves quality of life.

Chapel Hill, North Carolina
NCT06603246Recruiting· Phase 1
Study of inhaled GDC-6988 for mucus lung diseases

This study tests an inhaled medicine (GDC-6988) to see if it is safe and helps clear mucus from the lungs in people with mucus-related lung diseases like chronic bronchitis, COPD, or bronchiectasis. You may qualify if your lung function is fairly stable and you produce daily mucus.

Birmingham, Alabama
NCT06820749Enrolling by invitation· Phase 2
Study of HSK31858 tablets for lung mucus conditions

This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.

Beijing, Beijing Municipality
NCT06858748Recruiting
Mucus in airways: asthma, COPD, and chronic cough study

This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.

Vancouver, British Columbia
NCT07198347Not yet recruiting· Phase 3
New medicine for acute bronchitis with cough and phlegm

This study tests a new medicine, AG2001, to see if it safely helps adults with acute bronchitis (a sudden chest cold with cough and phlegm). If you have a recent, bothersome cough and sputum, this trial might offer a new treatment option.

NCT07443124Not yet recruiting
Simeox 200 for mucus clearance in bronchiectasis

This study is testing a new device called Simeox 200 to help clear mucus from your lungs. If you have bronchiectasis and produce a lot of mucus daily, this device might make it easier to breathe and reduce lung infections.

Charleston, South Carolina

Hear when a new Bronchitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.